Staburo GmbH

We are thrilled to announce that our team from Staburo GmbH will be participating in the PSI 2024 Conference, which will take place from Sunday, June 16th to Wednesday, June 19th at the Beurs van Berlage in Amsterdam, Netherlands. The PSI Conference is a premier event for statisticians and quantitative scientists involved in drug development and healthcare. This year’s conference is expected to draw between 350 and 450 experts from industry, academia, and regulatory agencies worldwide. The conference will span three days, offering a broad program filled with plenary and parallel sessions, breakout discussions, workshops, and a poster session. For this last one, our colleagues Maarten van Dijk, Şeyma Öztürk, Stephan Bischofberger and Hannes Buchner have prepared a poster as a joint work between them, and it will be presented by Managing Director Hannes Buchner. The poster contains a systematic review for which data from all recently published Phase III oncology trials was extracted from ClinicalTrials.gov. Following review of all 165 trials fitting the search criteria only a surprisingly low number of trials adjusted their cox model for additional prognostic covariates, a method which has been shown to lead to significant improvements of effect sizes. Additionally, our colleagues Laura Schlieker, Markus Waser, Rebecca Freudling and Yesilda Balavarca will be present on site and will participate in a variety of social events, including a welcome reception on Sunday, a networking event on Monday, and the grand gala dinner on Tuesday evening. We look forward to engaging with the vibrant community at PSI 2024 and hope to see you in Amsterdam! #datascience #biostatistics #datatransparency #bioinformatics #clinicalresearch #clinicaltrials #PSI2024 #conference

Our two colleagues Kathi Künnemann, PhD and Ulrike Fischer, both Senior Disclosure Managers and Medical Writers, attended the #EMWA conference 2024 in Valencia. It was a truly enriching experience not only for its professional and educational content but also for its warm and inclusive atmosphere. Each of our two colleagues proudly presented a poster, contributing to the wealth of knowledge shared at the event. Ulrike presented: ‘An attempt to translate estimands into plain language’ and Kathi presented: ‘Plain language summaries created with Artificial intelligence’. The opportunity to expand their understanding through workshops and engage in meaningful exchanges with other medical writers was invaluable. Highlights included high-quality presentations on AI, meeting the translators’ group, and insightful roundtable discussions as well as the sunny weather of Valencia. Highlights included high-quality presentations on AI, meeting the translators’ group, and insightful roundtable discussions as well as the sunny weather of Valencia.     #Staburo #Statistics #ClinicalTrials #biometricsociety #datascience #dataanalytics  #EMWA #Conference #MedicalWriting #AI #Networking #ValenciaMemories 

Thrilled to celebrate our recent Staburo GmbH team event, which kicked off with a warm-up session in a perfect weather, setting the tone for the exciting activities ahead. Runners tackled a 6 km route, while walkers enjoyed a comfortable 3 km stroll along the Isar in the southern part of Munich. This was followed by a company-themed quiz, that sparked some friendly competition and laughter. To conclude the day, we adjourned to a nearby restaurant, providing an opportunity for further networking and relaxation. A huge thanks to all participants for making it a memorable day! Looking forward to more exciting team moments together! #datascience #biostatistics #datatransparency #bioinformatics #clinicalresearch #clinicaltrials #TeamEvent #teambuilding  

With the slogan “Navigating the Sea of Data: Biometrics Guides the Way”, the 70th Biometric Colloquium took place at the University of Lübeck from February 28 – March 01, 2024. While various topics were presented, Maria Stark, Senior Data Scientist at Staburo GmbH, delved into practical aspects of planning and analyzing diagnostic studies in the "Statistics in Practice" invited session.   The talk was a joint work together with her former colleagues of Universitätsklinikum Hamburg Eppendorf. They covered several aspects such as the choice of a study design, definition of an estimand, calculation of the sample size and the analysis and report of the study results. The conference was a successful event, featuring three keynote presentations on statistical methods in high-dimensional genetic data, insights in the work at the European Medicines Agency and causal inference. This memorable experience for our colleague, Maria Stark, was concluded with a networking dinner hosted at the venue of the traditional restaurant "Schiffergesellschaft," followed by a guided city tour of Lübeck. #datascience #biostatistics #datatransparency #bioinformatics #clinicalresearch #clinicaltrials #Staburo #ibs #biometricsociety #dataanalytics

Imagine you are tasked with designing a phase II dose finding study to come up with a suitable dose for phase III. To accomplish this, the invited talk by Gabriele Bleckert from Staburo GmbH at the 9th German Pharm-Tox Summit in Munich on 14 March 2024 within the AGAH session gave good directions. Ten years ago, the Multiple Comparison Procedure and Modelling (MCP-Mod) Methodology was qualified by regulators as an efficient statistical methodology for model-based design and analysis of phase II dose finding studies under model uncertainty. The talk showcased two clinical trials in the indication Schizophrenia and Diabetes where MCP-Mod has been implemented successfully. MCP-Mod was motivated and key features of the methodology were explained with focus on MCP-Mod at analysis stage. Planning of MCP-Mod trials was elaborated in the subsequent talk by Sebastian Bossert from Boehringer Ingelheim. Many thanks to Ruwen Boehm and Barbara Schug from SocraTec R&D who chaired the AGAH (Arbeitsgemeinschaft für Angewandte Humanpharmakologie e. V.) session for inviting us to share our insights on MCP-Mod. Special thanks to Sebastian Bossert for the illuminating exchange on MCP-Mod. #datascience #biostatistics #datatransparency #bioinformatics #clinicalresearch #clinicaltrials

The presentation of our BVMA member companies continues 🚀 With a team of 80 employees, Staburo GmbH offers excellent data science to improve and save lives. Since 2010 we provide advanced and high-quality data science services for international pharmaceutical, CRO and biotech clients.   🌍 Working with pharma companies, we have a significant impact on the successful approval of several new therapies and are a reliable, flexible partner for our clients.   🌱 We strive for excellence while having a strong focus on healthy growth, diversity, fun and team spirit.   Our service and expertise cover the following areas:   📈 Clinical Statistics 🔬 Translational Medicine & Biomarkers 📊 Statistical Programming 💊 Pharmacokinetics/-dynamics ⛓ Bioinformatics 🔎 Health Technology Assessment 💡 Non-clinical Statistics 📝 Data Transparency 📌 Medical Writing 💻 Data Management   🌿 Our commitment   Staburo is committed to the highest ethical standards and integrity. For us, this also includes taking responsibility in a wide range of areas, such as legal, environmental, and social topics. Driven by passion, enthusiasm, and our willingness for continuous learning we aim to have a significant impact on the successful approval of several new therapies every year used by millions of patients worldwide.   💛 Our culture   We are proud of our very diverse environment which enriches our teamwork, knowledge, skills, and business results. It is essential to us to build an environment in which all Staburo members feel accepted, respected, integrated and comfortable.   Let’s deliver excellent data science to improve and save lives together. #BVMA #ClinicalResearch #KlinischeForschung #CRO #datascience #biostatistics #datatransparency #bioinformatics #clinicaltrials

February is already over, and we look back on some smaller, but great and fun team get togethers in our office at Staburo GmbH. As we continue to grow, it is always important that we create time and opportunities to get to know each other and exchange ideas. Beginning of the months we celebrated the carnival season with fresh doughnuts (German: Krapfen) in the office and enjoyed a relaxed coffee break together. A few weeks later this was followed by one of our monthly office days plus another movie night for all colleagues. On this day also a lot of our remote colleagues travelled to our office in Munich, and we had the chance to celebrate the 10th anniversary of one of our colleagues. As we have ‘Big Lebowski’ fans in our team, this film was on the programme and was accompanied by a presentation about the most important characters in the run-up to the film. We spent an entertaining und funny evening together including pizza and drinks. We always look forward to meeting our colleagues in our office – either for business meetings or for smaller after work events. Thanks for your great participation. #datascience #biostatistics #datatransparency #bioinformatics #clinicalresearch #clinicaltrials #teamevent